The Texas Legislature has passed a significant expansion of the state’s 2015 Compassionate Use Program, which allowed limited legal use of medical marijuana for certain epilepsy patients. The law now will include multiple sclerosis, other seizure disorders, autism, cancer, and other incurable neurodegenerative diseases. Also expanded was the number of licensed dispensaries. The new legislation legalizes low THC cannabidiol or “CBD” products, and hemp-derived products containing less than .3 percent of the THC, such as oils, sprays and nutritional supplements, will now be sold in Texas. Although employees should not be impaired by taking the low-THC CBD products, employers could face legal issues since a positive drug test could be triggered.